Catharina G Faber

Summary

Country: The Netherlands

Publications

  1. ncbi Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy
    Catharina G Faber
    Department of Neurology, University Medical Center Maastricht, Maastricht, The Netherlands
    Ann Neurol 71:26-39. 2012
  2. ncbi Entrapment in anti myelin-associated glycoprotein neuropathy
    Catharina G Faber
    Dept of Neurology, University Hospital Maastricht, 5800, 6202 AZ, Maastricht, The Netherlands
    J Neurol 256:620-4. 2009
  3. ncbi AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands
    Catharina G Faber
    Department of Neurology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands
    J Neurol 256:1719-23. 2009
  4. ncbi Gain-of-function Nav1.8 mutations in painful neuropathy
    Catharina G Faber
    Department of Neurology, University Medical Centre Maastricht, 6202 AZ Maastricht, The Netherlands
    Proc Natl Acad Sci U S A 109:19444-9. 2012
  5. ncbi Peripheral neuropathy in myotonic dystrophy type 1
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Peripher Nerv Syst 16:24-9. 2011
  6. ncbi Revised normative values for grip strength with the Jamar dynamometer
    Martine J H Peters
    Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Peripher Nerv Syst 16:47-50. 2011
  7. ncbi Fatigue and daytime sleepiness scale in myotonic dystrophy type 1
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Muscle Nerve 47:89-95. 2013
  8. ncbi Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre, PO Box 5800, Maastricht, AZ, 6202, The Netherlands
    J Cardiovasc Magn Reson 14:48. 2012
  9. ncbi Small-fibre neuropathies--advances in diagnosis, pathophysiology and management
    Janneke G Hoeijmakers
    Department of Neurology, University Medical Center Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Nat Rev Neurol 8:369-79. 2012
  10. ncbi Temperature threshold testing: a systematic review
    Mayienne Bakkers
    Department of Neurology Maastricht University Medical Center, Maastricht, The Netherlands
    J Peripher Nerv Syst 18:7-18. 2013

Collaborators

Detail Information

Publications19

  1. ncbi Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy
    Catharina G Faber
    Department of Neurology, University Medical Center Maastricht, Maastricht, The Netherlands
    Ann Neurol 71:26-39. 2012
    ..7, which is preferentially expressed in small diameter peripheral axons...
  2. ncbi Entrapment in anti myelin-associated glycoprotein neuropathy
    Catharina G Faber
    Dept of Neurology, University Hospital Maastricht, 5800, 6202 AZ, Maastricht, The Netherlands
    J Neurol 256:620-4. 2009
    ..In conclusion, increased sensitivity for entrapment may occur in anti-MAG neuropathy and contribute to part of the nerve damage...
  3. ncbi AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands
    Catharina G Faber
    Department of Neurology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands
    J Neurol 256:1719-23. 2009
    ....
  4. ncbi Gain-of-function Nav1.8 mutations in painful neuropathy
    Catharina G Faber
    Department of Neurology, University Medical Centre Maastricht, 6202 AZ Maastricht, The Netherlands
    Proc Natl Acad Sci U S A 109:19444-9. 2012
    ..8 mutations enhance the channel's response to depolarization and produce hyperexcitability in DRG neurons. These observations suggest that mutations of Na(v)1.8 contribute to painful peripheral neuropathy...
  5. ncbi Peripheral neuropathy in myotonic dystrophy type 1
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Peripher Nerv Syst 16:24-9. 2011
    ..In conclusion, peripheral nerve involvement may be one of the multisystemic manifestations of DM1, but is usually subclinical. Other causes should be excluded when sensory symptoms or signs are severe...
  6. ncbi Revised normative values for grip strength with the Jamar dynamometer
    Martine J H Peters
    Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Peripher Nerv Syst 16:47-50. 2011
    ..Hand dominance had no influence. Other personal factors only minimally influenced final values. This study provides revised normative GS values for the Jamar dynamometer...
  7. ncbi Fatigue and daytime sleepiness scale in myotonic dystrophy type 1
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Muscle Nerve 47:89-95. 2013
    ..Fatigue and excessive daytime sleepiness are frequent complaints in myotonic dystrophy type 1 (DM1) that often overlap. We aimed to construct a combined fatigue and daytime sleepiness rating scale for DM1 using the Rasch measurement model...
  8. ncbi Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre, PO Box 5800, Maastricht, AZ, 6202, The Netherlands
    J Cardiovasc Magn Reson 14:48. 2012
    ..Considering the importance of cardiomyopathy as a predictor of prognosis, we aimed to systematically evaluate and describe structural and functional cardiac alterations in patients with MD1...
  9. ncbi Small-fibre neuropathies--advances in diagnosis, pathophysiology and management
    Janneke G Hoeijmakers
    Department of Neurology, University Medical Center Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Nat Rev Neurol 8:369-79. 2012
    ..In this Review, we discuss recent advances in the diagnosis and pathophysiology of SFN, highlighting how improved understanding of these aspects of the disorder will contribute to better patient management...
  10. ncbi Temperature threshold testing: a systematic review
    Mayienne Bakkers
    Department of Neurology Maastricht University Medical Center, Maastricht, The Netherlands
    J Peripher Nerv Syst 18:7-18. 2013
    ..Consensus is needed to standardize the use of TTT as a diagnostic and follow-up tool in patients...
  11. ncbi [Small fibre neuropathy: knowledge is power]
    Jannkek G J Hoeijmakers
    Maastricht Universitair Medisch Centrum, Maastricht, The Netherlands
    Ned Tijdschr Geneeskd 156:A4224. 2012
    ..Treatment of small fibre neuropathy consists of symptomatic pain relief and, if possible, treatment of the underlying cause of the condition...
  12. ncbi Outcome measures in peripheral neuropathies: requirements through statements
    Ingemar S J Merkies
    Department of Neurology, Spaarne Hospital, Hoofddorp, The Netherlands
    Curr Opin Neurol 25:556-63. 2012
    ..The aim of this review is to inform and educate clinicians through statements about the most important clinimetric requirements for outcome measures in peripheral neuropathies...
  13. ncbi Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ)
    Mieke C E Hermans
    Department of Neurology, Maastricht University Medical Centre, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Neuromuscul Disord 20:310-8. 2010
    ..DM1-Activ is a practical, reliable and valid outcome measure that fulfils all clinimetric requirements. Further evaluation of this scale is needed to provide a nomogram for clinical use...
  14. ncbi Fatigue in immune-mediated neuropathies
    Ingemar S J Merkies
    Department of Neurology, Spaarne Hospital, Hoofddorp, The Netherlands
    Neuromuscul Disord 22:S203-7. 2012
    ..Aspects like the degree of known fatigue in these disorders, its impact on daily functioning and quality of life, the suggested underlying mechanisms, and possible therapeutic interventions for fatigue will be addressed in this review...
  15. ncbi Small fibre neuropathy
    Giuseppe Lauria
    Neuromuscular Diseases Unit, IRCCS Foundation, Carlo Besta Neurological Institute, Milan, Italy
    Curr Opin Neurol 25:542-9. 2012
    ..This review summarizes the most recent advances in classification, diagnostic assessment, and treatment of small fibre neuropathy (SFN)...
  16. ncbi Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale
    Sonja I van Nes
    Department of Neurology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands
    J Peripher Nerv Syst 14:268-78. 2009
    ..In conclusion, a 7-item linearly weighted Rasch-built modified FSS is presented for more proper assessment of fatigue in future studies in patients with immune-mediated neuropathies...
  17. ncbi [Statistical significance or clinical relevance?]
    Els K Vanhoutte
    Maastricht Universitair Medisch Centrum, afd Neurologie, Maastricht, The Netherlands
    Ned Tijdschr Geneeskd 154:A2516. 2010
    ..This was demonstrated using various MCID cut-off values...
  18. ncbi Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety
    Wouter A Pluijms
    Department of Anaesthesiology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Pain 15:783-8. 2011
    ..Subsequently, data were recruited on the efficacy and safety of spinal cord stimulation in this disorder...
  19. ncbi Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials
    Sonja I van Nes
    Department of Neurology, Erasmus Medical Centre, Rotterdam Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
    J Peripher Nerv Syst 13:136-47. 2008
    ....